ONCWF (Oncolytics Biotech) Accounts Payable & Accrued Expense : $3.45 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Oncolytics Biotech Accounts Payable & Accrued Expense?

Oncolytics Biotech's quarterly accounts payable & accrued expense declined from Sep. 2024 ($5.11 Mil) to Dec. 2024 ($3.36 Mil) but then increased from Dec. 2024 ($3.36 Mil) to Mar. 2025 ($3.45 Mil).

Oncolytics Biotech's annual accounts payable & accrued expense declined from Dec. 2022 ($2.69 Mil) to Dec. 2023 ($2.66 Mil) but then increased from Dec. 2023 ($2.66 Mil) to Dec. 2024 ($3.36 Mil).

Oncolytics Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oncolytics Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Accounts Payable & Accrued Expense Chart

Oncolytics Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.41

1.55

2.69

2.66

3.36

Oncolytics Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2.67	3.40	5.11	3.36	3.45

Oncolytics Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oncolytics Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (OTCPK:ONCWF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ONCY:USA ONC:Canada

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.